| |
 |
| |
Programme Highlights |
| |
QUICK LINKS TO FULL PROGRAMME - |
| |
|
| |
|
|
|
| |
General interest |
Science |
Practice |
| |
|
Getting the message across:
communicating risk and benefit to
patients |
|
Predicting safety benefits and risks in drug
development |
 |
The review of the new contract framework |
| |
|
Balancing risk and regulation: the
increasing role of patients and
pharmacists |
 |
Risk management: the key to pharmaceutical
quality |
 |
Statins as an early intervention: public health
versus individual choice |
| |
|
Regulation and balance: cost benefit
analysis |
 |
Therapeutic biomolecules and vaccines: reducing
future risk |
 |
Squaring the circle: protecting pharmacists and
patients |
| |
|
Ensuring the safety of herbal
medicines: pharmacovigilance and
interactions with drugs |
 |
Cox-2 inhibitors: blood, guts, fashion and politics |
 |
Getting the right balance for OTC medicines |
| |
 |
Prevention better than cure? |
 |
New scientists: recent advances in
pharmaceutical science |
 |
From prescribing to plastic surgery in community
pharmacy: opportunity and risk in a permissive age |
| |
|
Prevention versus treatment
following the emerging pattern of
blindness in the Western World |
 |
Quality by design: mitigating risk in drug
development |
 |
Thinking outside of the box: communicating risks
and benefits to people in special groups |
| |
|
 |
Reducing the risks of counterfeit |
 |
Supervision and responsible pharmacists |
| |
|
 |
From genomics to medicine |
 |
Always read the leaflet: improving the readability
of patient information leaflets |
| |
|
 |
Challenges in drug delivery |
 |
The risks and benefits of self-administration of
medicines in hospital |
| |
|
 |
Cutting-edge drug design |
 |
From Manchester to Malta: communicating to
patients across Europe |
| |
|
 |
Inhalation and drug delivery |
 |
Ask about medicines: what about the children? |
| |
|
 |
Risks and benefits: drug evaluation in the
21st Century |
 |
Pharmacists with a special interest |
| |
|
 |
Nanotechnology in drug delivery and medicine |
 |
Pharmacy in a secure environment |
| |
|
 |
Myths, rumours and evidence |
 |
Errors and risk: what is the link? |
| |
|
 |
Herbal medicinal products |
 |
Debate: Friend or foe? The media’s reporting of
risks and benefits |
| |
|
 |
Pharmacognosy and pharmaceutical chemistry |
|
|
| |
|
 |
Genotoxic impurities |
|
|
| |
|
 |
Debate: Homoeopathy or allopathy – which one
would you choose? |
|
|
| |
|
|
|
|
| |
Speakers at BPC 2007 will
include: |
| |
|
|
| |
 |
Professor Nick
Barber, Head of the Department of Practice and Policy, The
School of Pharmacy, University of London |
| |
 |
Professor Alison
Blenkinsopp, Professor of Pharmacy Practice, Keele
University |
| |
 |
Professor Nigel
Brown, Director, Biotechnology and Biological Sciences
Research Council |
| |
 |
Harry Cayton,
National Director for Patients and the Public, Department of Health |
| |
 |
Professor Sir
Colin Dollery, Senior Consultant, GlaxoSmithKline |
| |
 |
Dr Ben Goldacre,
Author, Bad Science Column, The Guardian |
| |
 |
Professor Chris
Hawkey, Professor of Gastroenterology, University of
Nottingham |
| |
 |
Lord Hunt of
Kings Heath, Minister of State for Quality, Department of
Health |
| |
 |
Dr Carole Longson,
Director, Health Technology Evaluation Centre, NICE |
| |
 |
Professor Theo
Raynor, Practice Chairman BPC 2007 |
| |
 |
Joanne Rule,
Chief Executive, CancerBACUP |
| |
 |
Olivia Timbs,
Editor, The Pharmaceutical Journal |
| |
 |
Peter White,
Broadcaster |
| |
 |
Professor Clive
Wilson, Science Chairman BPC 2007 |
| |
 |
Professor Kent
Woods, Chief Executive, Medicines and Healthcare products
Regulatory Agency |
| |
|
|
|
|
| |
Working with others: |
| |
BPC is a multi-disciplinary event and the
2007 programme was developed in conjunction with the following
organisations: |
| |
|
|
| |
Academy of Pharmaceutical Sciences |
Medicine and Healthcare products Regulatory Agency |
| |
British Pharmacological Society |
National Pharmacy Association |
| |
Company Chemists’ Association |
Prison Pharmacists’ Forum |
| |
European Federation for Pharmaceutical Sciences |
Sense About Science |
| |
Hospital Pharmacists Group |
The Pharmacists’ Defence Association |
| |
Industrial Pharmacists Group |
UKI Controlled Release Society |
| |
Joint Pharmaceutical Analysis Group |
|
| |
|
|
| |
QUICK LINKS TO FULL PROGRAMME - |
|
|
|
|
|
home
-
theme
- highlights -
programme -
social events -
call for papers
-
booking -
press releases -
awards |